Editorial Board
Loyola University Chicago, USA
| Biography Bruce Gaynes holds doctorate degrees in both pharmacy and optometry as well as a graduate degree in pharmacology from the Indiana University Medical Sciences Program. He holds a joint appointment at the Department of Veteran Affairs Medical Center, Hines, IL and Loyola University Stritch School of Medicine Department of Ophthalmology, Maywood, IL. Research Interest Ophthalmic drug delivery |  |
Charles University, Europe
| Biography Dr. Pavel Rozsival is a proffesor of Ophthalmology Clinic in Hradec Kralove, Charles University, Prague. He was born in Cheb, Czech Republic, 27th September 1950.He have published 4l5 papers and presented over 750 lectures.He has published books like Modern Cataract Surgery in 1994, Trends of current ophthalmology IX in 2014 and more. He was awarded with Vanysek medal from Czech Society of Cataract and Refractive Surgery in 2010. Dr. Rozsival was the first in Czech Republic who implanted AlphaCor arteficial cornea. He was among those who introduced modern IOL implantation in Czech Republic. He has the membership with European Society of Cataract and Refractive Surgery,European Glaucoma Society,and American Academy of Ophthalmology. He was President of Czech Society of Ophthalmology during 1997 – 2005 and vice-president during 2006 – 2009. Research Interest Glaucoma, Cataract and refractive surgery, Vitreoretinal surgery, Corneal transplant, Retinal Detachment, Intraocular implantations |
University of Arizona, USA
| Biography
Since August 1983 I had an uninterrupted career in different teaching and research positions with 5
different Universities in Asia, Europe and America. I published more than 40 peer reviewed articles in different reputed journals and contributed significantly to the field of ocular Physiology and Pharmacology.
In June 2005 I moved to the United States of America and since then I have been working as Assistant Professor including my present position at the University of Arizona. During this time I established a second model system, the primary culture of non pigmented ciliary epithelial cells. I published a large number of peer reviewed papers in many reputed journals with significant contribution to ocular physiology and pharmacology research.
In June 2005 I moved to the United States of America and since then I have been working as Assistant
Professor including my present position at the University of Arizona. During this time I established a
second model system, the primary culture of nonpigmented ciliary epithelial cells. I published a large
number of peer reviewed papers in many reputed journals with significant contribution to ocular
physiology and pharmacology research.
Pharmacology.In 2001 I was invited by the School of Optometry of the Hong Kong Polytechnic University to help them
to establish an Ocular Pharmacology laboratory and appointed me as a Research Fellow and Visiting
Lecturer. I worked there until June 2005. During this period I was able to adapt the intact eye
preparation to record multifocal ERG and this is the first in vitro ERG record in the world. I also taught
Pharmacology and Physiology to the optometry students.Since August 1983 I had an uninterrupted career in different teaching and research positions with 5
different Universities in Asia, Europe and America. I published more than 40 peer reviewed articles in
different reputed journals and contributed significantly to the field of ocular Physiology and
Pharmacology.Since August 1983 I had an uninterrupted career in different teaching and research positions with 5
different Universities in Asia, Europe and America. I published more than 40 peer reviewed articles in
different reputed journals and contributed significantly to the field of ocular Physiology and
Pharmacology.
I graduated with Doctor of Veterinary Medicine (DVM) degree in 1982 from Bangladesh Agricultural
University. I was awarded University Prize for securing First position in the First Class and appointed as a
Lecturer in the Department of Physiology and Pharmacology in the following year. During the tenure of
my lectureship position I completed MSc in Pharmacology degree in 1985, again with distinction and
secured First Class. I was promoted to Assistant professor in 1987 and worked in this position until Sept.
1990.
In 1990 I was awarded Commonwealth Scholarship by the Association of Universities in the United
Kingdom to do my PhD in Pharmacology. Strictly speaking this is the start of my research career. I
completed PhD in 1994 from the University of Glasgow, UK and because of my outstanding contribution
in research I was immediately offered Postdoc position and worked for this University until 2001. During
this period I had an outstanding achievement in establishing an experimental model, the perfused intact
eye system to study ocular drugs. I published a number of manuscripts utilizing this model system with
significant contribution the field.
In 2001 I was invited by the School of Optometry of the Hong Kong Polytechnic University to help them
to establish an Ocular Pharmacology laboratory and appointed me as a Research Fellow and Visiting
Lecturer. I worked there until June 2005. During this period I was able to adapt the intact eye
preparation to record multifocal ERG and this is the first in vitro ERG record in the world. I also taught
Pharmacology and Physiology to the optometry students.
In June 2005 I moved to the United States of America and since then I have been working as Assistant
Professor including my present position at the University of Arizona. During this time I established a
second model system, the primary culture of nonpigmented ciliary epithelial cells. I published a large
number of peer reviewed papers in many reputed journals with significant contribution to ocular
physiology and pharmacology research.Since August 1983 I had an uninterrupted career in different teaching and research positions with 5
different Universities in Asia, Europe and America. I published more than 40 peer reviewed articles in
different reputed journals and contributed significantly to the field of ocular Physiology and
Pharmacology.
I graduated with Doctor of Veterinary Medicine (DVM) degree in 1982 from Bangladesh Agricultural
University. I was awarded University Prize for securing First position in the First Class and appointed as a
Lecturer in the Department of Physiology and Pharmacology in the following year. During the tenure of
my lectureship position I completed MSc in Pharmacology degree in 1985, again with distinction and
secured First Class. I was promoted to Assistant professor in 1987 and worked in this position until Sept.
1990.
In 1990 I was awarded Commonwealth Scholarship by the Association of Universities in the United
Kingdom to do my PhD in Pharmacology. Strictly speaking this is the start of my research career. I
completed PhD in 1994 from the University of Glasgow, UK and because of my outstanding contribution
in research I was immediately offered Postdoc position and worked for this University until 2001. During
this period I had an outstanding achievement in establishing an experimental model, the perfused intact
eye system to study ocular drugs. I published a number of manuscripts utilizing this model system with
significant contribution the field.
In 2001 I was invited by the School of Optometry of the Hong Kong Polytechnic University to help them
to establish an Ocular Pharmacology laboratory and appointed me as a Research Fellow and Visiting
Lecturer. I worked there until June 2005. During this period I was able to adapt the intact eye
preparation to record multifocal ERG and this is the first in vitro ERG record in the world. I also taught
Pharmacology and Physiology to the optometry students.
In June 2005 I moved to the United States of America and since then I have been working as Assistant
Professor including my present position at the University of Arizona. During this time I established a
second model system, the primary culture of nonpigmented ciliary epithelial cells. I published a large
number of peer reviewed papers in many reputed journals with significant contribution to ocular
physiology and pharmacology research.Since August 1983 I had an uninterrupted career in different teaching and research positions with 5
different Universities in Asia, Europe and America. I published more than 40 peer reviewed articles in
different reputed journals and contributed significantly to the field of ocular Physiology and
Pharmacology.
I graduated with Doctor of Veterinary Medicine (DVM) degree in 1982 from Bangladesh Agricultural
University. I was awarded University Prize for securing First position in the First Class and appointed as a
Lecturer in the Department of Physiology and Pharmacology in the following year. During the tenure of
my lectureship position I completed MSc in Pharmacology degree in 1985, again with distinction and
secured First Class. I was promoted to Assistant professor in 1987 and worked in this position until Sept.
1990.
In 1990 I was awarded Commonwealth Scholarship by the Association of Universities in the United
Kingdom to do my PhD in Pharmacology. Strictly speaking this is the start of my research career. I
completed PhD in 1994 from the University of Glasgow, UK and because of my outstanding contribution
in research I was immediately offered Postdoc position and worked for this University until 2001. During
this period I had an outstanding achievement in establishing an experimental model, the perfused intact
eye system to study ocular drugs. I published a number of manuscripts utilizing this model system with
significant contribution the field.
In 2001 I was invited by the School of Optometry of the Hong Kong Polytechnic University to help them
to establish an Ocular Pharmacology laboratory and appointed me as a Research Fellow and Visiting
Lecturer. I worked there until June 2005. During this period I was able to adapt the intact eye
preparation to record multifocal ERG and this is the first in vitro ERG record in the world. I also taught
Pharmacology and Physiology to the optometry students.
In June 2005 I moved to the United States of America and since then I have been working as Assistant
Professor including my present position at the University of Arizona. During this time I established a
second model system, the primary culture of nonpigmented ciliary epithelial cells. I published a large
number of peer reviewed papers in many reputed journals with significant contribution to ocular
physiology and pharmacology research.
Research Interest My research focuses around ocular anterior and posterior segment physiology, pharmacology and cell biology, particularly with regard to aqueous humor secretion and glaucoma. My specific interests are: 1. Mechanism of aqueous humor secretion 2. Identification, functional characterization and regulation of transport proteins involved in aqueous humor secretion. 3. Pathophysiology of retina in relation to glaucoma. |  |
Cincinnati Childrens Hospital Medical Center, USA
| Biography Dr. Taosheng Huang isa physician-scientist, currently he is aprofessor with tenure in Human Genetics, Director, Program of Mitochondrial Medicine. Associate Director of the Molecular Diagnostic laboratory at Cincinnati Children's Hospital Medical Center (CCHMC). Before he moved to CCHMC, he was was an associate professor with tenure in Pediatrics, Developmental and Cell Biology, and Pathology at University of California, Irvine. Previously, he was also the director for the MitoMed Molecular Diagnostic laboratory and Director of the Cardiovascular Genetic Clinic. Dr. Huang graduated from Fujian Medical University in 1983 andmoved to New York for Ph.D. study at Mount Sinai Medical School in 1997. Research Interest Clinically, Dr. Huang is interested in Genetics of mitochondrial diseases, Genetic syndromes with congenital cardiac defects, Pharmacogenomics, Prenatal screening and prenatal diagnosis and New born screening. |  |
Menoufyia University Hospital, Egypt
| Biography Working as an Ophthalmologist for almost 15 years, covering a variety of challenging roles within the specialty, I have been able to acquire a wealth of experience in undertaking a range of surgical procedures. Alongside developing my core practical competencies, my involvement in research has significantly improved my ability to collate and analyze complex information, forming conclusions based on my findings. Through this, I am also confident in presenting information clearly and precisely at meetings and conferences, and these transferable skills have been of enormous benefit in managing patient care and communication with both patients and colleagues on a day to day basis. Research Interest Having enjoyed my involvement in various research activities over the past few years, I opted to undertake a research project entitled “Non-Penetrating Glaucoma Surgery” at Aberdeen University Hospital, which I submitted as a doctoral thesis to the Faculty of Medical Sciences in 2007. In addition, I have submitted the following papers for publication and presented my research findings at a number of national and international meetings. |  |
Indiana University School of Medicine, USA
| Biography I have recently recruited to the IU school of optometry (IUSO) as tenured associate professor since March 1st, 2015. I originally came from Taiwan and got my Ph.D. in molecular biology at the University of Cincinnati in 1993. I have successfully managed RO1 grants from NIH/NEI since 2001 and have a broad background in mouse molecular genetics with 25 years of experience working with transgenic and knockout mouse model for human diseases such as cancer and ocular surface diseases. I have published over 80 peer-reviewed papers, review articles, and book chapters mostly related to the eye development and diseases. I have served as an editorial board members since 2011 in Molecular Vision, a peer-reviewed journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system. I have been invited to give seminar on corneal morphogenesis and development at the Gordon Research Conference (Biology & Pathobiology of the Cornea) February 16-21, 2014; Ventura, CA. Recently, I was selected as an Ad Hoc reviewer to join NIH Biology of Visual System (BVS) study section at Bethesda, Washington DC, February 19-20, 2015. I am “hands-on” performing experimental protocols myself and directing pre- and post-doctoral fellows in a hypothesis-oriented project toward a Ph.D. dissertation. I am also capable of giving classroom lecture to undergraduate and graduate students. My teaching experience and interests are strongly focused in the areas of molecular genetics, biochemistry, and developmental biology in the epithelial biology and eye development. I expect to continue growing in this role, and to attract students to my research program where I can help guide them through the process of applying their own skills and knowledge in becoming excellent clinician, researchers, and teachers themselves. Indiana University School of Optometry focuses on fundamental biological questions related to the function of the visual system or health of the eye. I believe that my expertise and experience have prepared me to successfully carry out the mission of both teaching and research in IUSO. Research Interest The main focus of my research is to use conditional gene loss-of-function and gain-of-function mouse model to elucidate the signal transduction and transcriptional regulations of ocular anterior segment development and diseases. We have established several transgenic mouse phenotypes which resemble human ocular diseases such as ocular surface squamous neoplasia (OSSN), Keratoconjunctivitis sicca (dry eye symdrome), Blepharophimosis, Ptosis, and Epi-canthus inversus Syndrome (BPES), and congenital juvenile angle closure glaucoma. |  |
Aligarh Muslim University, India
| Biography Prof.(Dr.) Shamim Ahmad is Distinguished Professor of Ocular Microbiology and Officer In-Charge as well as Teacher In-Charge (Administrative Affairs) at Ocular Microbiology Section , Institute of Ophthalmology ,JN Medical College ,Faculty of Medicine , Aligarh Muslim University ,Aligarh ,India being working since January,10,1983 . Prof. Ahmad had has also served as Faculty on deputation from AMU Aligarh for about 5 years at Faculties of Medicine in the Department of Clinical Microbiology, Al-Arab Medical University, Libya and Department of Medical Microbiology, College of Medicine ,Faculty of Medicine, King Khalid University, Saudi Arabia. He worked at the Department of Microbiology, Central Drug Research Institute (CDRI) , Lucknow ,India as a CSIR(New Delhi) - Fellow to earn his Ph.D. degree in 1982.He obtained his Post Doc. training in various Departments of Microbiology at the Universities of world repute in six countries. Prof. Ahmad has been a recipient of at least 6 International Fellowships including "DAAD (W. Germany) , "JSPS"(Japan)"ROYAL SOC. London"(UK),"DAAD"(Germany),"TUBA"(Turkey) and "SAIA"(Slovak Republic) as a visiting Professor mostly sponsored by Govt. of India and respective World Academies . During this period , Dr. Ahmad has also assumed key administrative positions including Manager , Ahmadi School for the Visually Challenged at AMU Aligarh and abroad. Research Interest
-Bacterial and Fungal Infections of the Eye and their Chemotherapy.
-Molecular Aspect of ANTIBIOTIC-RESISTANCE IN CLINICAL BACTERIA ESPECIALLY IN EYE INFECTIONS using most modern molecular techniques.
-ROLE OF PLASMIDS / B-LACTAMAMSES in drug resistance and pathogenicity of Gram positive especially Staphylococci and Gram negative clinical bacteria , including ocular pathogens and their mechanism at molecular level.
-Biochemical and Molecular Approaches on the Spread of Antibiotic-resistance genes from different ecosystems to human beings in health and disease in EYE ENVIRONMENT.
-Molecular Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) from Various infections particularly from Ocular infections specially keratitis Patients.
-Strategies to prevent ENDOPHTHALMITIS after Intra Ocular Surgeries ,using ANIMAL MODELS.
-Role of Preoperative and Post –Operative antibiotics in various SURGERIES especially in intraocular surgeries.
-Application of Novel Approaches to Combat Drug-Resistant Bacteria and New Strategies Combating Bacterial Infections using alternate approaches and agents.
-Use of LYSOSTAPHIN in most dreaded Eye infections (KERATITIS and ENDOPHTHALMITIS) caused multiple Resistanr Superbugs especially MRSAs.
- Exploration of Medicinal Plants producing Antimicrobial products and UNANI FORMULATIONS FOR THEIR ANTIMICROBIAL ACTIVITY AGAINST MULTI_RESISTANT SUPER BUGS PARTICULARLY----MRSA from eye and other clinical sources.
-Antimicrobial and Clinical uses of “Honey” for their Antimicrobial Activity and MEDICINAL USES specially in Ophthalmology and Surgery, Paediatrics, Dentistry, Gynaecology, Plastic surgery, ENT ,Unani Medicines and related fields.
-Clinical Applications of ANTIMICROBIAL PHOTODYNAMIC THERAPY (a PDT) in combating multi-resistant pathogens especially of eye infections.-Bacterial and Fungal Infections of the Eye and their Chemotherapy.
-Molecular Aspect of ANTIBIOTIC-RESISTANCE IN CLINICAL BACTERIA ESPECIALLY IN EYE INFECTIONS using most modern molecular techniques.
-ROLE OF PLASMIDS / B-LACTAMAMSES in drug resistance and pathogenicity of Gram positive especially Staphylococci and Gram negative clinical bacteria , including ocular pathogens and their mechanism at molecular level.
-Biochemical and Molecular Approaches on the Spread of Antibiotic-resistance genes from different ecosystems to human beings in health and disease in EYE ENVIRONMENT.
-Molecular Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) from Various infections particularly from Ocular infections specially keratitis Patients.
-Strategies to prevent ENDOPHTHALMITIS after Intra Ocular Surgeries ,using ANIMAL MODELS.
-Role of Preoperative and Post –Operative antibiotics in various SURGERIES especially in intraocular surgeries.
-Application of Novel Approaches to Combat Drug-Resistant Bacteria and New Strategies Combating Bacterial Infections using alternate approaches and agents.
-Use of LYSOSTAPHIN in most dreaded Eye infections (KERATITIS and ENDOPHTHALMITIS) caused multiple Resistanr Superbugs especially MRSAs.
- Exploration of Medicinal Plants producing Antimicrobial products and UNANI FORMULATIONS FOR THEIR ANTIMICROBIAL ACTIVITY AGAINST MULTI_RESISTANT SUPER BUGS PARTICULARLY----MRSA from eye and other clinical sources.
-Antimicrobial and Clinical uses of “Honey” for their Antimicrobial Activity and MEDICINAL USES specially in Ophthalmology and Surgery, Paediatrics, Dentistry, Gynaecology, Plastic surgery, ENT ,Unani Medicines and related fields.
-Clinical Applications of ANTIMICROBIAL PHOTODYNAMIC THERAPY (a PDT) in combating multi-resistant pathogens especially of eye infections.-Bacterial and Fungal Infections of the Eye and their Chemotherapy.
-Molecular Aspect of ANTIBIOTIC-RESISTANCE IN CLINICAL BACTERIA ESPECIALLY IN EYE INFECTIONS using most modern molecular techniques.
-ROLE OF PLASMIDS / B-LACTAMAMSES in drug resistance and pathogenicity of Gram positive especially Staphylococci and Gram negative clinical bacteria , including ocular pathogens and their mechanism at molecular level.
-Biochemical and Molecular Approaches on the Spread of Antibiotic-resistance genes from different ecosystems to human beings in health and disease in EYE ENVIRONMENT.
-Molecular Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) from Various infections particularly from Ocular infections specially keratitis Patients.
-Strategies to prevent ENDOPHTHALMITIS after Intra Ocular Surgeries ,using ANIMAL MODELS.
-Role of Preoperative and Post –Operative antibiotics in various SURGERIES especially in intraocular surgeries.
-Application of Novel Approaches to Combat Drug-Resistant Bacteria and New Strategies Combating Bacterial Infections using alternate approaches and agents.
-Use of LYSOSTAPHIN in most dreaded Eye infections (KERATITIS and ENDOPHTHALMITIS) caused multiple Resistanr Superbugs especially MRSAs.
- Exploration of Medicinal Plants producing Antimicrobial products and UNANI FORMULATIONS FOR THEIR ANTIMICROBIAL ACTIVITY AGAINST MULTI_RESISTANT SUPER BUGS PARTICULARLY----MRSA from eye and other clinical sources.
-Antimicrobial and Clinical uses of “Honey” for their Antimicrobial Activity and MEDICINAL USES specially in Ophthalmology and Surgery, Paediatrics, Dentistry, Gynaecology, Plastic surgery, ENT ,Unani Medicines and related fields.
-Clinical Applications of ANTIMICROBIAL PHOTODYNAMIC THERAPY (a PDT) in combating multi-resistant pathogens especially of eye infections.
|  |
Cullen Eye Institute, USA
| Biography Dr. Koray GUMUS, MD, FEBOphth, received his Doctorate of Medicine with high honours from Hacettepe University School of Medicine in Ankara, Turkey in 2000. He completed an ophthalmology residency in the Department of Ophthalmology at Hacettepe University School of Medicine in Ankara, Turkey in 2004. Following residency training, he joined the faculty of the Department of Ophthalmology at Erciyes University School of Medicine, Kayseri, Turkey in 2005. He worked with Prof. Stephen C. Pflugfelder and completed a postdoctoral research fellowship program in Ocular Surface Center at Baylor College of Medicine, Houston, Texas between 2009 and 2010. He was promoted to Associate Professorship in 2011 and currently works in the Department of Ophthalmology at Erciyes University School of Medicine, Kayseri, Turkey. He is board certified by the European Board of Ophthalmology, Turkish Board of Ophthalmology and International Council of Ophthalmology. He worked as a co-editor in the Erciyes Medical Journal between 2007 and 2012. He currently serves as an editorial board member of “World Journal of Clinical Cases” and “Journal of Ocular Diseases and Therapeutics” and “Journal of Ophthalmology” Dr. Gumus is an appointed member of several national and international committees. He serves as a board member of the International Ocular Surface Society (IOSS), founder and coordinator of the Young Ophthalmologist (YO) Committee of Turkish Ophthalmology Society (TOS) and TCOD-YO advisory board member of international examinations. He’s also been working as a consultant, trainer and speaker for medical device and pharmaceutical companies. Dr. Gumus is an active member of American Academy of Ophthalmology (AAO), The Association for Research in Vision and Ophthalmology (ARVO) International Ocular Surface Society (IOSS), Turkish Ophthalmology Society (TOS), Turkish Ophthalmology Society – Young Ophthalmologist Committee, Turkish Republics Ophthalmology Society. Academically, Dr. Gumus has authored over 40 peer-reviewed journal publications and book chapters primarily in the field of ocular surface diseases. Additionally, he is a reviewer for several prestigious ophthalmology journals. Research Interest Corneal and ocular surface diseases (keratoconus, dry eye, blepharitis, meibomian gland dysfunction, allergic conjunctivitis, corneal infections, pterygium and etc.) Contact lens applications Cataract and Refractive surgery (Excimer LASER, phacic IOL implantation, refractive lensectomy) Corneal & limbal transplantation |  |
Indiana University School of Medicine, USA
| Biography In 2005 I moved to the United States of America and shifted my research field from plant physiology to ocular molecular biology. I refreshed my knowledge and skills in this new field and published papers in peer-reviewed journals like Development, Journal of Cell Science, Journal of neuroscience and IOVS. I also presented my interesting data at ARVO each year and Gordon Research Conference in 2014. Research Interest Using specific transgenic mouse models to study the roles of Notch and Wnt signaling pathways during corneal development and hemostasis. |  |
University of Louisville School of Medicine, USA
| Biography Dr. Borchman is a Professor of Ophthalmology and Visual Sciences at the University of Louisville. He is also an adjunct Professor in the Departments of Chemistry, Biochemistry and Physiology and Biophysics. He earned a Ph.D. in Chemistry from Wayne State University MI in 1986 and is the author of over 100 peer reviewed articles in scientific journals. He is/was principal or co-investigator on 7 major peer awarded government grants totaling over 10 million dollars to study cataract and dry eye. He has given over 250 scientific presentations around the world. Professor Borchman is currently a paid consultant for, Sanofi Inc., Bridgewater, NJ; Global Pharmacovigilance and Epidemiology Dept. of Genzyme, Cambridge, MA, Consultant, Coleman Research Group Inc. Coleman Research Group, Raleigh, NC and Allergan Inc., Irvine, CA. He is on the editorial board of: the Clinical Journal of Ophthalmology, Journal of Ophthalmic Diseases, Austin Journal of Clinical Ophthalmology and the Ocular Surface. He is a paid Senior Editor for Medjaden Bioscience Limited, Hong Kong. Research Interest Dr. Borchman received B.S. and Ph.D. degrees from Wayne State Unviersity before completing postdoctoral training at Mount Sinai Hospital in New York. His research is focused on ophthalmology and visual sciences, where his team recently characterized changes in human lens lipid composition with regard to age and cataract. This research led to the discovery of dihydrosphingomyelin, a major lens phospholipid. Dr. Borchman is also leading a group of research associates in studying the structure and interactions of the lipid tear film, which has yet to be fully described on a molecular level. |  |
Acibadem University School of Medicine, TURKEY
| Biography Dr. Ali Riza Cenk Celebi finished High school education in Nazilli Anatolian High School with honored as the best top among three students in 1999. He attended Medical school in University of Hacettepe in 1999 and graduated in 2005 (third position with 3.56/4.00 degree). He completed residency of Ophthalmology in Hacettepe University School of Medicine Department of Ophthalmology between 2005 and 2010. During his residency, in 2009 he was accepted as a short term observer visiting fellow in University of Louisville Kentucky Lions Eye Center Rounsavall Eye Clinic, Vitreoretinal and Medical Retina Unit. During his chief residency period he successfully passed International Council of Ophthalmology (ICO) “Basic Science Assessment in Ophtalmology including Optics and Refraction” and “Clinical Science Assessment in Ophthalmology” examinations. He worked in Nigde State Hospital Department of Ophthalmology for obligatory service to government between 2010 and 2013. He became an Assistant Professor of Ophthalmology in 2014 in Acibadem University School of Medicine Department of Ophthalmology. He has been working at Acibadem Atakent Education and Research Hospital since 2014. Research Interest Dry eye, glaucoma and small incision cataract surgery. |  |
University of Stellenbosch, SOUTH AFRICA
| Biography
Prof David Meyer graduated MB ChB from the University of Stellenbosch in 1976. He was the recipient of the Stellenbosch Merit Bursary in 1971 as a First Year Medical Student. He also received the Noristan Bursary for a Fifth Year Medical Student as well as the Noristan Gold Medal as Medical Student.
After completing his Internship at the Tygerberg Hospital in 1977, he worked as a General Practitioner in Ficksburg in the Free State before joining the SA Defence Force during 1979 - 1981. From June 1981 till December 1986 he worked as a General Practitioner in Kroonstad (one of his partners was Dr Bruce Staples, currently working as an Ophthalmologist in Bethlehem). During this time, he obtained the MFGP (SA) as well as the Honns BSc degree in Pharmacology from the Potchefstroom University.
Prof Meyer has also recently spent several extensive periods at the King Khaled Eye Specialist Hospital and King Saud University, Riyadh, Kingdom of Saudi Arabia, as Professor of Ophthalmology in the Oculoplastic Division, where he was responsible for the training of Fellows and Residents in Oculoplastic, Orbit and Lacrimal surgery. This experience enabled him to enhance his research, clinical and surgical expertise significantly in International Oculoplastics during these visits.
Prof David has recently found sound scientific evidence that Medicine is indeed present in the genes.of the Meyer family, he believes that it has something to do with passion. "To become a doctor, must be your passion. It must be in your heart."
He completed his training as a Registrar in Ophthalmology at the University of Stellenbosch in 1990 under the late Professor Basson van Rooyen. He then did a Fellowship for one year in Cataract and Refractive surgery with Dr Howard Gimbel at the Gimbel Eye Centre in Calgary, Alberta, Canada and at the Loma Linda University in California in the United States of America.Prof David Meyer graduated MB ChB from the University of Stellenbosch in 1976. He was the recipient of the Stellenbosch Merit Bursary in 1971 as a First Year Medical Student. He also received the Noristan Bursary for a Fifth Year Medical Student as well as the Noristan Gold Medal as Medical Student.
After completing his Internship at the Tygerberg Hospital in 1977, he worked as a General Practitioner in Ficksburg in the Free State before joining the SA Defence Force during 1979 - 1981. From June 1981 till December 1986 he worked as a General Practitioner in Kroonstad (one of his partners was Dr Bruce Staples, currently working as an Ophthalmologist in Bethlehem). During this time, he obtained the MFGP (SA) as well as the Honns BSc degree in Pharmacology from the Potchefstroom University.
He completed his training as a Registrar in Ophthalmology at the University of Stellenbosch in 1990 under the late Professor Basson van Rooyen. He then did a Fellowship for one year in Cataract and Refractive surgery with Dr Howard Gimbel at the Gimbel Eye Centre in Calgary, Alberta, Canada and at the Loma Linda University in California in the United States of America.
Research Interest The research of Prof David Meyer focuses on an alternative treatment for glaucoma, an eye disease which is characterised by elevated pressure in the eyeball. The treatment, which is unique to the Stellenbosch University, relies on the use of a topical preparation to relieve pressure in the eyeball. The molecule works on the receptors in the eyeball, leading to a reduction in intraocular pressure. |  |
University of Missouri, USA
| Biography Ashim K. Mitra received his Ph.D. in Pharmaceutical Chemistry in 1983 from the University of Kansas. He joined the University of Missouri-Kansas City in 1994 as Chairman of Pharmaceutical Sciences. He is also Vice Provost for Interdisciplinary Research, UM Curators’ Professor of Pharmacy, Co-Director, Vision Research Center UMKC School of Medicine. He has over 30 years of experience in the field of ocular drug delivery and disposition. He authored and co-authored over 350+ refereed articles, 60 book chapters in the area of formulation development and ocular drug delivery, awarded 10 patents, and presented (along with his research group) well over 710+ presentations/abstracts at national and international scientific meetings. This work has attracted over six million dollars in funding from government agencies such as the National Institutes of Health (NIH), Department of Defense (DOD) and pharmaceutical companies. He served as Co-chair, of the USP Council of Experts, General Chapter <771> Ophthalmic Preparations Expert Panel U.S. Pharmacopeia. In 2007, he was named one of two recipients for the ARVO/Pfizer Ophthalmic Translational Research Award for excellence in the areas of research and fundamental scientific discoveries, including concepts and novel technologies, leading to clinical evidence of diagnosis, prevention, or amelioration of the pathological eye and/or an understanding of the normal vision processes. He is also the recipient of a numbers of research awards from NIH, AAPS, AACP, and numerous pharmaceutical organizations. In February 2014 he received the Chancellor’s Award for Excellence in Graduate Mentoring from the University of Missouri-Kansas City He has served as a regular member of the National Institute of Health (NIH) Pharmacology & Toxicology Study Section and on the NIH Gene and Drug Delivery Study Section. He has extensive memberships in academic, professional and scholarly societies. He also serves on numerous scientific editorial advisory boards. Dr. Mitra’s laboratory has been engaged in ocular drug delivery for nearly 30 years. Current efforts are directed to: (1) delineate mechanisms of transscleral permeation of both small and large molecules, (2) develop new strategies to deliver neuroprotective and antiproliferative agents from topical eye drops, (3) to design new biopolymers for long-term topical and subconjunctival administrations and finally, (4) delineate the expression of various transporters and receptor on the cornea, blood-retinal and blood aqueous barrier and utilize these cell absorptive mechanisms to deliver small and large molecule therapeutics. Research Interest My research interest includes ocular delivery system, transporter/receptor specific ligand based delivery to viral reservoir sites particularly the eye and brain. The brain parenchymal cells are protected by highly impermeable capillary cells (blood brain barrier). Similarly, the ocular blood vessels in the retinal choroid (blood retinal barrier) and the anterior segment-aqueous humor (blood-aqueous barrier) are barriers to drug delivery to the eye. Research interest can be categorized into two main areas: delivery and targeting of antiviral agents and development of noninvasive delivery systems for peptides and protein; serves on several National Institutes of Health Study Sections including AIDS and Related Research; editor of a book on "Ophthalmic Drug Delivery Systems" and a journal series on "Advanced Drug Delivery Reviews. |  |
Hospital of Verona, Italy
| Biography Dr Bellucci was born in Italy in 1952. He completed his medical education in Padua in 1976, and received his residency in Ophthalmology in 1980 at the same University. His hospital activity ran from 1978 to 2015, for the last 14 years as Chief of Ophthalmology in Verona, Italy. He served as Professor of the School of Ophthalmology at the University of Verona from 1979 to 2015. A father of 4 children, he lives on lake Garda, Italy, where he runs his practice Research Interest
Surgical cornea
cataract surgery
intraocular lenses
optics of the human eye
corneal refractive surgery
femtosecond lasers
|  |
Akron Children's Hospital, USA
| Biography
Dr. Simone L. Li is a Clinician Scientist in the Division of Ophthalmology and the Co-
Director of the Laboratory of Visual and Ocular Motor Physiology at Akron Children's
Hospital, OH. Dr. Li performs independent research on the developing visual system of
infants and children. She also supervises the performance of routine
electrophysiological testing on patients and families.
Dr. Li earned her PhD in Vision Science from Syracuse University and then an OD
from the New England College of Optometry in Boston. Prior to coming to Akron
Children's Hospital, she completed her postdoctoral fellowship in Clinical Vision
Science at the Retina Foundation of the Southwest in Dallas, TX. During her PhD and
postdoctoral training, Dr. Li studied various aspects of the visual system, including
stereo vision and binocular function. She also carried out research on the
novel treatments for amblyopia (lazy eye) in children using binocular iPad games and
dichoptic movies.Dr. Simone L. Li is a Clinician Scientist in the Division of Ophthalmology and the Co-
Director of the Laboratory of Visual and Ocular Motor Physiology at Akron Children's
Hospital, OH. Dr. Li performs independent research on the developing visual system of
infants and children. She also supervises the performance of routine
electrophysiological testing on patients and families.
Dr. Li earned her PhD in Vision Science from Syracuse University and then an OD
from the New England College of Optometry in Boston. Prior to coming to Akron
Children's Hospital, she completed her postdoctoral fellowship in Clinical Vision
Science at the Retina Foundation of the Southwest in Dallas, TX. During her PhD and
postdoctoral training, Dr. Li studied various aspects of the visual system, including
stereo vision and binocular function. She also carried out research on the
novel treatments for amblyopia (lazy eye) in children using binocular iPad games and
dichoptic movies.
Research Interest
Dr. Li’s research interests include:
1. amblyopia
2. binocular vision
3. pediatric ophthalmology
4. nystagmus
5. psychophysics and computational modeling of the human stereo vision1. amblyopia
2. binocular vision
3. pediatric ophthalmology
4. nystagmus
5. psychophysics and computational modeling of the human stereo vision1. amblyopia
2. binocular vision
3. pediatric ophthalmology
4. nystagmus
5. psychophysics and computational modeling of the human stereo vision
|  |
Tehran University of Medical Sciences, Iran
| Biography I have received my medical degree from Tehran University of Medical Sciences, Tehran, Iran. I am a research associate in Farabi Eye Hospital affiliated with Tehran University of Medical Sciences. My main research interest is anterior segment and corneal eye diseases especially keratoconus which I am currently focusing on studying different aspects of keratoconus disorder that have resulted in more than 35 articles to date.
I have received my medical degree from Tehran University of Medical Sciences,
Tehran, Iran. I am a research associate in Farabi Eye Hospital affiliated with Tehran
University of Medical Sciences. My main research interest is anterior segment and
corneal eye diseases especially keratoconus which I am currently focusing on studying
different aspects of keratoconus disorder that have resulted in more than 35 articles to
date.
Research Interest Ophthalmology Surgery | .jpg) |
